Chris Degnan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Verrica Pharmaceuticals Inc., Galera Therapeutics, Inc., and UroGen Pharma Ltd..

2019 was Chris Degnan's most active year for acquiring shares with 2 total transactions. Chris Degnan's most active month to acquire stocks was the month of December. 2025 was Chris Degnan's most active year for disposing of shares, totalling 2 transactions. Chris Degnan's most active month to dispose stocks was the month of September. 2018 saw Chris Degnan paying a total of $45,000.00 for 3,000 shares, this is the most they've acquired in one year. In 2025 Chris Degnan cashed out on 6,686 shares for a total of $37,120.55, their largest year based on trade value.